1.373 articles found

Toward Harmonizing Quantification of Dopamine Neuron Imaging Biomarkers in Parkinson's Disease: The Centamine Scale.

Fan Z, Searle G, Rizzo G, Albani J, Cella P, Comley R, Klein G, Passamonti L, Salinas C, Schwarz AJ, Iaccarino L, Tamagnan G, Eberling J, Marek K, Seibyl J, Gunn RN, Parkinson's Progression Markers Initiative.

Ann Neurol · 2026-01-20

DOI: 10.1002/ana.78116PMID: 41556298

Total flavonoids isolated from Fructus Mume (Prunus mume Sieb. et Zucc.) mitigate Parkinson's disease progression by promoting neuronal mitophagy via activation of the CaMKKβ/AMPK signaling pathway.

Wang C, Feng X, Zhang W, Huang L, Lu X, Sun M, Gao M, Wen X.

J Ethnopharmacol · 2026-01-19

DOI: 10.1016/j.jep.2026.121244PMID: 41564984

Neutrophil-to-Lymphocyte Ratio Predicts Anxiety Progression in Parkinson's Disease.

Yang D, Liu Z, Lin S, Wang J, Zhang S, Xu J, Cai H, Zhang B, Lin H, Huang S, Chen G.

Mov Disord Clin Pract · 2026-01-12

DOI: 10.1002/mdc3.70519PMID: 41521920

Clinical Correlates of a Ratio-Based Progression Index in Parkinson's Disease: Insights from a Large Cross-Sectional Cohort.

Onder H, Melek I, Bozkus R, Comoglu S.

Mov Disord Clin Pract · 2026-01-12

DOI: 10.1002/mdc3.70528PMID: 41525713

Obstructive sleep apnea, biomarker profiles, and clinical progression in Parkinson's disease: Longitudinal effects of CPAP therapy.

Zhu S, An D, Liu X.

Sleep Med · 2026-01-05

DOI: 10.1016/j.sleep.2026.108766PMID: 41499940

ProSAAS overexpression arrests progression of motor deficits in a rat alpha-synuclein model of Parkinson’s disease

Shu Z, Lam H, Videlock E, Lindberg I, Maidment N.

Translational neurodegeneration · 2026-01-01

Parkinson's disease progression is shaped by longitudinal changes in cerebral compensation.

Johansson ME, Toni I, Bloem BR, Helmich RC.

Brain · 2026-01-01

DOI: 10.1093/brain/awaf302PMID: 40796318

Lutein Attenuates Parkinson's Disease Progression by Regulating Mitochondrial Function via the TRIM31/Drp1 Signaling Pathway.

Duan J, Duan W, Pu X, Ma C, Huang H, Xu Z.

J Integr Neurosci · 2026-01-01

DOI: 10.31083/jin45758PMID: 41609041

Caudate-Centric Triphasic Network Reconfiguration Characterizes the Early Progression of Cognitive Impairment in Parkinson's Disease: A Simultaneous PET/fMRI Study.

Zhang W, Li G, Mao F, Zhao H, Zhao L, Liang L, Guo Y, Sun C, Yang Y, Wang X, Luo X.

J Integr Neurosci · 2026-01-01

DOI: 10.31083/jin46634PMID: 41762057

Heel-Tapping-Based Parkinson's Disease Progression Monitoring Using Smart Insoles.

Almuteb I, Hua R, Emad-Ud-Din M, Vanegas-Arroyave N, Wang Y.

IEEE Trans Neural Syst Rehabil Eng · 2026-01-01

DOI: 10.1109/tnsre.2026.3674714PMID: 41843502

Speech Biomarkers From Smartphone Calls Track Progression in REM Sleep Behavior Disorder and Parkinson's Disease.

Šimek M, Tykalová T, Novotný M, Illner V, Kouba T, Šubert M, Sovka P, Švihlík J, Růžička E, Šonka K, Dušek P, Rusz J.

Ann Neurol · 2025-12-30

DOI: 10.1002/ana.78140PMID: 41467327

Sex-dependent immune activation shapes disease progression in a model of Parkinson's disease.

Beauchamp LC, Palumbo LA, Lanser TB, Baig M, Cox LM.

Biol Sex Differ · 2025-12-24

DOI: 10.1186/s13293-025-00809-1PMID: 41437096